Phase I Dose Escalation Study of Intravenously Administered S64315 in Combination With Orally Administered Venetoclax in Patients With Acute Myeloid Leukaemia.
Clinical trial NCT03672695 · COMPLETED
Trial details
- NCT number
- NCT03672695
- Sponsor
- Institut de Recherches Internationales Servier
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-28
- Primary completion
- 2022-11-12
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.